AMRX (Amneal Pharmaceuticals) Short-Term Debt to Capital

Corporate company logo of Amneal Pharmaceuticals (AMRX)

The price chart for Amneal Pharmaceuticals (AMRX) allows for an assessment of the business's financial stability, which relies on stable demand for medications regardless of market fluctuations. The current indicator is 7.18. High barriers to entry in the industry are driven by strict FDA oversight and the high cost of sterile manufacturing facilities. Profit growth is driven by the market launch of complex injectables and the expansion of biosimilar sales.

Ratio of Short-Term Indebtedness to Capital: Amneal Pharmaceuticals Inc (AMRX) for 07/04/2022 - 11/01/2026

Analytical breakdowns for Amneal Pharmaceuticals

- stock quotes and analyst forecast:
Stock Price Amneal Pharmaceuticals Inc|AMRX - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Amneal Pharmaceuticals, Inc.|AMRX - Enterprise Value
- book capitalization information:
Net Assets per Single Share Amneal Pharmaceuticals|AMRX - Accounting Value of Company|Market Value to Book Value Ratio amneal.com|AMRX - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Amneal Pharmaceuticals|AMRX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Amneal|AMRX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Amneal Pharmaceuticals, Inc.|AMRX - Long-Term Debt|Company Current Liabilities Amneal Pharmaceuticals|Quick Ratio amneal.com
- company profitability and valuation multiples indicators:
AMRX - Final Profit
Fundamental valuation:AMRX Amneal Pharmaceuticals Inc
Brand item of Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals (AMRX) generic production exhibits exceptional resilience to macroeconomic shocks due to stable demand for affordable medicines. By analyzing the short-term leverage chart, an investor assesses the ratio of liabilities maturing within one year to equity, which helps determine the business's dependence on current refinancing and default risks amid rising rates within a non-cyclical industry.

Competitors of Amneal Pharmaceuticals (AMRX)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Liquidia Inc.|GLPG (Galapagos NV) - Short-Term Debt to Capital|Short-Term Debt to Capital anipharmaceuticals.com|Short-Term Debt to Equity Ratio MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Pacira PCRX|ARS Corp (SPRY) - Current Liabilities to Capital|TBPH: Short-Term Debt to Equity Ratio|aquestive.com - Short-Term Loans to Capital Ratio|SCPH: Short-Term Debt to Capital|Tectonic Therapeutic - Ratio of Short-Term Indebtedness to Capital|TNXP (Tonix Pharmaceuticals Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital SXT China SXTC|Short-Term Debt to Equity Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital EXOZ (eXoZymes)|Short-Term Debt to Capital Oramed ORMP|ENTX - Short-Term Debt to Equity|MindWalk Therapeutics (HYFT) - Short-Term Debt to Equity Ratio|ABVC BioPharma (ABVC) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio CPIX|QNTM (Quantum BioPharma) - Short-Term Debt to Capital|Current Liabilities to Capital FibroGen Inc FGEN|Short-Term Debt to Capital TELO|Short-Term Debt to Capital ranitherapeutics.com (RANI)|Short-Term Debt to Equity Synergy CHC SNYR|Rallybio Corp - Short-Term Debt to Equity|LEXX: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital PULM (Pulmatrix Inc)|ftzy.com.cn (PTHL) - Short-Term Debt to Equity|Current Liabilities to Equity APM (Aptorum Group)|LYRA (Lyra Therapeutics, Inc.) - Short-Term Debt to Capital|IBO: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TNFA|Short-Term Debt to Capital cbdmd.com (YCBD)|Short-Term Debt to Equity PainReform Limited PRFX|Ratio of Short-Term Indebtedness to Capital CYTO|LIPO - Short-Term Debt to Equity|optinose.com (OPTN) - Short-Term Debt to Equity Ratio|PIRS: Short-Term Debt to Capital|Procaps Group (PROC) - Short-Term Debt to Capital|PTPI (Petros) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Qilian International Corp (QLI)|Short-Term Debt to Capital SLRN|TFFP - Current Liabilities to Capital